norfloxacin and lactulose

norfloxacin has been researched along with lactulose in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Campillo, NE; Guerra, A; Páez, JA1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Alvarez, M; Arrese, M; Glasinovic, JC; González, R; Pérez-Ayuso, RM; Riquelme, A; Soza, A1
Colle, I; De Keukeleire, K; Pauwels, W; Van Vlierberghe, H1

Reviews

1 review(s) available for norfloxacin and lactulose

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

4 other study(ies) available for norfloxacin and lactulose

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:3

    Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical

2010
Increased orocecal transit time in patients with nonalcoholic fatty liver disease.
    Digestive diseases and sciences, 2005, Volume: 50, Issue:6

    Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Breath Tests; Fatty Liver; Female; Gastrointestinal Agents; Gastrointestinal Transit; Humans; Intestinal Diseases; Lactulose; Male; Middle Aged; Norfloxacin

2005
'Hepatic' encephalopathy because of spontaneous mesenterico-caval shunt.
    Liver international : official journal of the International Association for the Study of the Liver, 2008, Volume: 28, Issue:7

    Topics: Anti-Bacterial Agents; Collateral Circulation; Fatty Liver; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Mesenteric Veins; Middle Aged; Norfloxacin; Treatment Outcome; Vena Cava, Inferior

2008